Clinical Trial Update: ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer

View source ↗

Summary

A completed clinical trial evaluating ARFI, VisR and DDAI ultrasound to improve discrimination between malignant and unresponsive breast cancers; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Breast Cancer | Status: COMPLETED | Results posted: 2024-12-09